Approved indications
Intramuscular haloperidol lactate is approved for rapid control of severe symptoms in schizophrenia and other psychotic disorders, and for acute agitation or delirium when oral antipsychotics are not appropriate or feasible.

Off‑label uses and evidence
Clinicians may use IM haloperidol off‑label for agitation in dementia, delirium in medically ill or postoperative patients, and severe behavioral disturbance (including in palliative or ICU settings), supported mostly by clinical experience, observational studies, and some randomized trials compared with other antipsychotics or sedatives.

Efficacy expectations
Onset of calming usually begins within 20 to 30 minutes after IM injection, with peak effect within about 1 to 2 hours; many patients experience reduced agitation and clearer thinking, though full stabilization of psychosis often requires ongoing oral or long‑acting treatment. Compared with similar first‑generation antipsychotics, efficacy for acute agitation is broadly similar; versus second‑generation agents, haloperidol is effective but may carry a higher risk of movement‑related side effects, while having relatively low risk of weight gain or metabolic changes.

Typical dosing and administration
For adults with acute agitation or psychosis, common intramuscular doses are 2 to 5 mg given as a single injection, repeated every 4 to 8 hours as needed, with many clinicians limiting total daily doses to about 20 mg; lower initial doses (for example 0.5 to 2 mg) are often used in older adults or debilitated patients. The injection is administered by a healthcare professional deep into a large muscle (such as the buttock or thigh); it is not intended for self‑injection and is not given intravenously.

Special dosing instructions
Clinicians may adjust the dose based on age, body weight, medical conditions, other medications, and response, using the lowest effective dose for the shortest necessary time, and transitioning to oral or long‑acting formulations once the person is stable. Additional medicines (such as benzodiazepines or anticholinergics) may be used alongside haloperidol to improve comfort or reduce movement‑related side effects, but require careful monitoring.

Missed dose guidance
Because this is usually given as a one‑time or short‑term injection in a supervised setting, missed doses are uncommon; if a scheduled dose is missed during ongoing treatment, the healthcare team will decide whether and when to re‑dose based on current symptoms and safety.

Overdose
Signs of overdose can include very severe drowsiness, marked muscle stiffness, agitation, confusion, seizures, breathing problems, or fainting due to heart rhythm changes. Overdose is a medical emergency requiring immediate evaluation in an emergency department, where supportive care, heart monitoring, and treatment of complications are provided.

Common side effects
Frequently reported effects include drowsiness, dizziness, restlessness or inner tension (akathisia), muscle stiffness or tremor, dry mouth, and constipation; these can appear within hours to days of dosing and range from mild to bothersome, often improving with dose adjustment or additional medicines to relieve movement symptoms.

Serious or rare adverse effects
Seek immediate medical attention for very rigid muscles, high fever, confusion, fast or irregular heartbeat, severe sweating, or unstable blood pressure (possible neuroleptic malignant syndrome); uncontrollable movements of the face, tongue, or limbs (tardive dyskinesia); severe muscle spasms of the neck, eyes, or jaw (acute dystonia); fainting, palpitations, or seizures; or signs of severe allergic reaction such as rash, swelling, or difficulty breathing.

Warnings and precautions
Use with caution in people with heart disease, history of QT‑prolongation or arrhythmias, electrolyte disturbances, Parkinson’s disease, dementia with Lewy bodies, liver impairment, or a history of seizures. In older adults with dementia‑related psychosis, antipsychotics are associated with an increased risk of death and stroke. During pregnancy, use is generally reserved for situations where benefits outweigh risks; small amounts pass into breast milk, so breastfeeding decisions should be individualized with a clinician. Dose reductions are often needed in older or frail patients.

Relative safety compared with other drugs
Compared with many second‑generation antipsychotics, haloperidol has lower risk of weight gain, diabetes, and cholesterol changes but higher risk of movement disorders and acute dystonia, especially at higher doses or with rapid parenteral use; like other antipsychotics, it can affect heart rhythm and requires careful dosing and monitoring.

Side‑effect reporting and safety updates
Side effects should be reported to the prescribing clinician and can also be reported directly to the FDA MedWatch program; up‑to‑date safety communications are available on the FDA’s website and through pharmacy or healthcare system alerts.

Drug and substance interactions
Haloperidol can interact with many medications that affect heart rhythm (such as some antiarrhythmics, certain antibiotics, and other antipsychotics), increasing the risk of QT‑prolongation and serious arrhythmias. It also interacts with drugs that alter its breakdown in the liver (for example, certain antidepressants, anticonvulsants, and HIV medicines), which can raise or lower haloperidol levels. Combining haloperidol with other medicines that cause drowsiness or slow breathing (such as opioids, benzodiazepines, or alcohol) can increase sedation and breathing risk. Some over‑the‑counter products, herbal supplements, and recreational drugs can intensify side effects or reduce effectiveness, so all substances should be reviewed with a clinician or pharmacist.

Food, alcohol, and procedures
Food does not significantly affect intramuscular dosing, but alcohol should be avoided because it can worsen drowsiness, judgment, and blood‑pressure changes. Before surgery or procedures with anesthesia or sedation, patients should inform the care team that they are receiving haloperidol, as this can influence medication choices and monitoring.

Precautions and conditions making use unsafe
Use may be contraindicated or require extreme caution in people with known QT‑prolongation, recent heart attack, uncompensated heart failure, severe electrolyte abnormalities, severe central nervous system depression, or allergy to haloperidol. Extra care is needed in those with liver disease, thyroid disease, seizure disorders, Parkinson’s disease, or dementia, and in older adults who are more sensitive to side effects.

Monitoring needs
Clinicians may obtain an electrocardiogram (ECG) before and during treatment in patients at risk for heart rhythm problems, and may periodically check electrolytes and, when indicated, liver function. Blood pressure, heart rate, temperature, and mental status are typically monitored closely around the time of injection, especially in acutely ill or medically fragile patients.

Q: How fast does intramuscular haloperidol lactate start working for agitation?
A: Many people begin to calm within about 20 to 30 minutes after the injection, with peak effect in roughly 1 to 2 hours, though exact timing varies by dose, other medications, and individual factors.

Q: Why would a doctor choose an injection instead of a haloperidol pill?
A: The intramuscular injection is used when rapid control of severe agitation or psychosis is needed and the person cannot or will not take oral medicine, or when reliable absorption of a pill is uncertain.

Q: How long does one dose of haloperidol injection last?
A: A single intramuscular dose often provides several hours of symptom control, and clinicians may repeat doses or switch to oral or long‑acting forms depending on how long treatment is needed.

Q: Can intramuscular haloperidol cause long‑term side effects?
A: Short‑term use at modest doses has a lower risk of long‑term movement problems, but repeated or high‑dose exposure over time can contribute to tardive dyskinesia or other persistent side effects, so clinicians aim to use the lowest effective dose and reassess regularly.

Q: Is haloperidol lactate safe in older adults?
A: It can be used cautiously in older adults, often at lower doses, but there is increased risk of side effects, including movement problems, confusion, falls, and, in dementia‑related psychosis, a higher risk of death, so benefits and risks must be carefully weighed.

Storage
Store vials at room temperature (generally 68°F to 77°F / 20°C to 25°C), protected from light, and do not freeze; keep in the original packaging until use and out of reach of children.

Disposal
Used vials, syringes, and needles should be placed in a puncture‑resistant sharps container and disposed of according to local pharmacy, clinic, or community sharps‑disposal programs; do not throw loose needles or vials in household trash.